35
ALZHEON, INC. files Form D
Company raise update · Raising · Offering $150M · Sold $126.3M · FRAMINGHAM, MA · filed 2025-02-10
55
ALZHEON, INC. raises $78.8M under Reg D
Company raise · Raising · FRAMINGHAM, MA · Form D filed 2026-09-10
$50M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Christopher Noel Dunn | Director |
| Neil W. Flanzraich | Director |
| Diane K. Jorkasky, M.D. | Director |
| John K. Hey, Ph.D. | Chief Scientific Officer |
| Susan K. Abushakra, M.D. | Chief Medical Officer |
| Muneer K. Satter | Director |
| Jordan W. Heller | Director |
| Aidan K. Power, MRCPsych | Chief Development Officer |
| Gino K. Santini | Director |
| Kenneth K. Mace | Treasurer and Chief Financial Officer |
| Martin Tolar, M.D., Ph.D. | President and Chief Executive Officer |
| Adem K. Albayrak | Chief Data Officer |
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
35
ALZHEON, INC. files Form D
Company raise update · Closed · Offering $125M · Sold $125M · FRAMINGHAM, MA · filed 2025-01-02